跳至主要内容
临床试验/NCT01572779
NCT01572779已完成2 期

A Multicentre, Cluster Randomised, Placebo-controlled, Open-label Pilot Study of Back Strain Monitor (BSM) With Feedback Compared With the BSM Without Feedback in Subjects With Moderate Lower Back Pain.

Pro-Active Medical Pty Ltd18 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2009年11月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
112
试验地点
18
主要终点
Quadruple Visual Analogue Scale (QVAS)

研究概览

简要总结

A postural bio-feedback device worn by subjects for 4-10 hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group. The device records movement and muscle activity data relating to the lower back. Bio-feedback is delivered to the subject as an audible tone, visual cue or vibration and aims to prompt the subject to alter their posture or position in line with recommendations given by the treating practitioner. Four small sensors are adhered to the lower back and send data wirelessly to a data logger carried in the pocket by the subject (the size of a small mobile phone).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject provides informed consent
  • Age between 18 and 65 years of age
  • At least moderate intensity low back pain (LBP) and/or back related leg pain, as defined by a QVAS score > 3 (Carragee, Spine 2000).
  • Initial QVAS score of > 3 out of 10
  • Subjects must be assessed by the practitioner as Sub Acute (3 to 12 weeks post onset of low back pain (LBP) or Chronic (> 12 weeks post onset of low back pain (LBP).

排除标准

  • Lower back surgery within previous twelve (12) months.
  • Females who are pregnant.
  • Subjects with a severe hearing impairment.
  • Evidence of non mechanical contributing cause for lower back pain e.g. neoplasm, infection, fracture, inflammatory disorder.
  • Preceding chronic neurological changes (Sub Acute group only).
  • Implanted medical device (spinal cord stimulator, intrathecal pump or peripheral nerve stimulator)
  • Nerve block, spinal injection or anesthetic procedure for the treatment of lower back pain within 12 months of the study.
  • Significant medical abnormalities or conditions that in the opinion of the Practitioner would interfere either with the ability to complete the study or the evaluation of the investigational device's safety and efficacy.
  • Recent history of a significant medical-surgical intervention that in the judgment of the Practitioner would interfere either with the ability to complete the study or the evaluation of the investigative device's safety and efficacy.
  • Known allergic skin reaction to tapes and plasters.
  • Subject who is currently enrolled in an investigational drug or device study.

研究组 & 干预措施

Control

Placebo Comparator

The BSM device without feed-back

干预措施: BSM device with no bio-feedback (Device)

Intervention

Experimental

BSM device with bio-feedback

干预措施: BSM device with bio-feedback (Device)

结局指标

主要结局

Quadruple Visual Analogue Scale (QVAS)

时间窗: over 12 months

Pain Scale

Roland Morris Disability Questionaire (RMDQ-23)

时间窗: over 12 months

Functional Outcome measure

Patient Specific Functional Scale (PSFS)

时间窗: over 12 months

Functional Outcome Measure

次要结局

  • The change over time from baseline in the range of movement, recorded by the device. Measured in degrees of movement in the three anatomical planes.(over 12 months)

研究者

发起方
Pro-Active Medical Pty Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验